Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials.
Chen, L-C
Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials. [electronic resource] - Journal of clinical pharmacy and therapeutics Dec 2006 - 565-76 p. digital
Publication Type: Journal Article; Meta-Analysis; Systematic Review
0269-4727
10.1111/j.1365-2710.2006.00774.x doi
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Cyclooxygenase Inhibitors--adverse effects
Humans
Naproxen--adverse effects
Randomized Controlled Trials as Topic
Risk
Stroke--chemically induced
Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials. [electronic resource] - Journal of clinical pharmacy and therapeutics Dec 2006 - 565-76 p. digital
Publication Type: Journal Article; Meta-Analysis; Systematic Review
0269-4727
10.1111/j.1365-2710.2006.00774.x doi
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Cyclooxygenase Inhibitors--adverse effects
Humans
Naproxen--adverse effects
Randomized Controlled Trials as Topic
Risk
Stroke--chemically induced